Annexin Pharmaceuticals AB documents

Explore the latest documents from Annexin Pharmaceuticals AB, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.

Description

Event date

Documents and forms

2025

Q2 2025

Jul 17, 2025

Interim report

Q1 2025

May 14, 2025

Interim report

2024

Q4 2024

Feb 6, 2025

Annual report

Interim report

Q3 2024

Oct 17, 2024

Interim report

Q2 2024

Jul 18, 2024

Interim report

Q1 2024

Apr 12, 2024

Interim report

2023

Q4 2023

Feb 9, 2024

Interim report

Q3 2023

Oct 18, 2023

Interim report

Q2 2023

Aug 3, 2023

Interim report

Q1 2023

May 17, 2023

Interim report

2022

Q4 2022

Feb 7, 2023

Report

Q3 2022

Nov 3, 2022

Interim report

Q2 2022

Aug 23, 2022

Interim report

Q1 2022

May 30, 2022

Interim report

2021

Q4 2021

Feb 3, 2022

Interim report

Q3 2021

Nov 30, 2021

Interim report

Q2 2021

Aug 19, 2021

Interim report

Q1 2021

May 6, 2021

Interim report

2020

Q4 2020

Feb 4, 2021

Interim report

Q3 2020

Oct 29, 2020

Interim report

Q2 2020

Aug 21, 2020

Interim report

Q1 2020

May 7, 2020

Interim report

2019

Q4 2019

Jan 28, 2020

Interim report

Q3 2019

Oct 31, 2019

Interim report

Q2 2019

Aug 22, 2019

Interim report

Q1 2019

May 2, 2019

Interim report

2018

Q4 2018

Jan 31, 2019

Interim report

Q3 2018

Oct 31, 2018

Interim report

Q2 2018

Aug 20, 2018

Interim report

Q1 2018

Apr 24, 2018

Interim report

2017

Q4 2017

Jan 31, 2018

Interim report

Q3 2017

Oct 31, 2017

Interim report

Q2 2017

Aug 16, 2017

Interim report

Q1 2017

May 15, 2017

Interim report